Sommaire

• • ·Table of Contents

    Page :A1

    
• • ·Editorial Board

    Page :A8

    
• • ·Information for Readers

    Page :A9

    
• • ·Correction

    Page :900

    
• • ·Correction

    Page :901

    

• Trial Design

  • ·GENESIS-PRAXY (GENdEr and Sex determInantS of cardiovascular disease: From bench to beyond-Premature Acute Coronary SYndrome)

    Page :741

    Louise Pilote, Igor Karp

    Résumé Résumé Plan Plan
  • ·A novel algorithm for individualized cardiac resynchronization therapy: Rationale and design of the adaptive cardiac resynchronization therapy trial

    Page :747

    Henry Krum, Bernd Lemke, David Birnie, Kathy Lai-Fun Lee, Kazutaka Aonuma, Randall C. Starling, Maurizio Gasparini, John Gorcsan, Tyson Rogers, Alex Sambelashvili, Amy Kalmes, David Martin

    Résumé Résumé Plan Plan  
  • ·Rationale and design of the PRAETORIAN trial: A Prospective, RAndomizEd comparison of subcuTaneOus and tRansvenous ImplANtable cardioverter-defibrillator therapy

    Page :753

    Louise R.A. Olde Nordkamp, Reinoud E. Knops, Gust H. Bardy, Yuri Blaauw, Lucas V.A. Boersma, Johannes S. Bos, Peter Paul H.M. Delnoy, Pascal F.H.M. van Dessel, Antoine H.G. Driessen, Joris R. de Groot, Jean Paul R. Herrman, Luc J.L.M. Jordaens, Kirsten M. Kooiman, Alexander H. Maass, Mathias Meine, Yuka Mizusawa, Sander G. Molhoek, Jurjen van Opstal, Jan G.P. Tijssen, Arthur A.M. Wilde

    Résumé Résumé Plan Plan  
  • ·Rationale and design of a randomized study to determine the value of central Blood Pressure for GUIDing managEment of hypertension: The BP GUIDE study

    Page :761-767

    James E. Sharman, Thomas H. Marwick, Walter P. Abhayaratna, Michael Stowasser

    Résumé Résumé Plan Plan  
  • ·Rationale and design of the Cangrelor versus standard therapy to acHieve optimal Management of Platelet InhibitiON PHOENIX trial

    Page :768

    Sergio Leonardi, Kenneth W. Mahaffey, Harvey D. White, C. Michael Gibson, Gregg W. Stone, Gabriel W. Steg, Christian W. Hamm, Matthew J. Price, Meredith Todd, Markus Dietrich, Dianne Gallup, Tiepu Liu, Simona Skerjanec, Robert A. Harrington, Deepak L. Bhatt

    Résumé Résumé Plan Plan  

• Clinical Investigations

  • ·Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers for treatment of ischemic heart disease: Future research needs prioritization

    Page :777

    Matthew J. Crowley, Benjamin J. Powers, Evan R. Myers, Amanda J. McBroom, Gillian D. Sanders

    Résumé Résumé Plan Plan  
  • ·Multiple biomarkers at admission are associated with angiographic, electrocardiographic, and imaging cardiovascular mechanistic markers of outcomes in patients undergoing primary percutaneous coronary intervention for acute ST-elevation myocardial infarction

    Page :783-789

    Peter Damman, Wichert J. Kuijt, Pier Woudstra, Joost D.E. Haeck, Karel T. Koch, Youlan L. Gu, Jan P. van Straalen, Johan Fischer, Jan G.P. Tijssen, Mitchell W. Krucoff, Robbert J. de Winter

    Résumé Résumé Plan Plan  
  • ·Physical function and independence 1 year after myocardial infarction: Observations from the Translational Research Investigating Underlying disparities in recovery from acute Myocardial infarction: Patients' Health status registry

    Page :790-796

    John A. Dodson, Suzanne V. Arnold, Kimberly J. Reid, Thomas M. Gill, Michael W. Rich, Frederick A. Masoudi, John A. Spertus, Harlan M. Krumholz, Karen P. Alexander

    Résumé Résumé Plan Plan  
  • ·Variations in practice and outcomes in patients undergoing primary percutaneous coronary intervention in the United States and Canada: Insights from the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX AMI) trial

    Page :797-803

    Rajendra H. Mehta, Padma Kaul, Renato D. Lopes, Manesh R. Patel, Yinggan Zheng, Karen S. Pieper, Robert C. Welsh, Paul W. Armstrong, Christopher B. Granger

    Résumé Résumé Plan Plan
  • ·International variation in use of oral anticoagulation among heart failure patients with atrial fibrillation

    Page :804-811

    Jorge Suarez, Jonathan P. Piccini, Li Liang, John J. Atherton, Christopher S. Hayward, Henry Krum, Gregg C. Fonarow, Renato D. Lopes, Adrian F. Hernandez

    Résumé Résumé Plan Plan  
  • ·Percutaneous left ventricular partitioning in patients with chronic heart failure and a prior anterior myocardial infarction: Results of the PercutAneous Ventricular RestorAtion in Chronic Heart failUre PaTiEnts Trial

    Page :812

    Ernest L. Mazzaferri, Sinisa Gradinac, Dragan Sagic, Petar Otasevic, Ayesha K. Hasan, Thomas L. Goff, Horst Sievert, Nina Wunderlich, Serjan D. Nikolic, William T. Abraham

    Résumé Résumé Plan Plan  
  • ·Combined use of high-sensitivity cardiac troponin T and N-terminal pro-B type natriuretic peptide improves measurements of performance over established mortality risk factors in chronic heart failure

    Page :821-828

    Marta de Antonio, Josep Lupon, Amparo Galan, Joan Vila, Agustin Urrutia, Antoni Bayes-Genis

    Résumé Résumé Plan Plan  
  • ·The changing definition of contrast-induced nephropathy and its clinical implications: Insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2)

    Page :829-834

    Nicklaus K. Slocum, P. Michael Grossman, Mauro Moscucci, Dean E. Smith, Herbert D. Aronow, Simon R. Dixon, David Share, Hitinder S. Gurm

    Résumé Résumé Plan Plan  
  • ·Assessing the role of eptifibatide in patients with diffuse coronary disease undergoing drug-eluting stenting: The INtegrilin plus STenting to Avoid myocardial Necrosis Trial

    Page :835.e1

    Giuseppe Biondi-Zoccai, Marco Valgimigli, Massimo Margheri, Antonio Marzocchi, Corrado Lettieri, Amerigo Stabile, A. Sonia Petronio, Giorgio Binetti, Leonardo Bolognese, Pietro Bellone, Gennaro Sardella, Marco Contarini, Imad Sheiban, Sebastiano Marra, Federico Piscione, Francesco Romeo, Antonio Colombo, Giuseppe Sangiorgi

    Résumé Résumé Plan Plan  
  • ·Understanding childhood obesity in America: Linkages between household income, community resources, and children's behaviors

    Page :836-843

    Taylor F. Eagle, Anne Sheetz, Roopa Gurm, Alan C. Woodward, Eva Kline-Rogers, Robert Leibowitz, Jean DuRussel-Weston, LaVaughn Palma-Davis, Susan Aaronson, Catherine M. Fitzgerald, Lindsey R. Mitchell, Bruce Rogers, Patricia Bruenger, Katherine A. Skala, Caren Goldberg, Elizabeth A. Jackson, Steven R. Erickson, Kim A. Eagle

    Résumé Résumé Plan Plan  
  • ·Baseline metabolomic profiles predict cardiovascular events in patients at risk for coronary artery disease

    Page :844

    Svati H. Shah, Jie-Lena Sun, Robert D. Stevens, James R. Bain, Michael J. Muehlbauer, Karen S. Pieper, Carol Haynes, Elizabeth R. Hauser, William E. Kraus, Christopher B. Granger, Christopher B. Newgard, Robert M. Califf, L. Kristin Newby

    Résumé Résumé Plan Plan  
  • ·Retrospective cohort analysis of 926 tricuspid valve surgeries: Clinical and hemodynamic outcomes with propensity score analysis

    Page :851

    Guillaume Marquis-Gravel, Denis Bouchard, Louis P. Perrault, Pierre Pagé, Hugues Jeanmart, Philippe Demers, Michel Carrier, Raymond Cartier, Nancy C. Poirier, Yves Hébert, Michel Pellerin

    Résumé Résumé Plan Plan  
  • ·Systemic right ventricular longitudinal strain is reduced in adults with transposition of the great arteries, relates to subpulmonary ventricular function, and predicts adverse clinical outcome

    Page :859-866

    Gerhard-Paul Diller, Jelena Radojevic, Aleksander Kempny, Rafael Alonso-Gonzalez, Liodakis Emmanouil, Stefan Orwat, Lorna Swan, Anselm Uebing, Wei Li, Konstantinos Dimopoulos, Michael A. Gatzoulis, Helmut Baumgartner

    Résumé Résumé Plan Plan  
  • ·The SPIRIT V Diabetic Study: A randomized clinical evaluation of the XIENCE V everolimus-eluting stent vs the TAXUS Liberté paclitaxel-eluting stent in diabetic patients with de novo coronary artery lesions

    Page :867

    Eberhard Grube, Bernard Chevalier, Giulio Guagliumi, Peter C. Smits, Marrianne Stuteville, Cécile Dorange, Peggy Papeleu, Upendra Kaul, Vladimír Džavík

    Résumé Résumé Plan Plan  
  • ·Long-term clinical and angiographic outcomes of diabetic patients after revascularization with early generation drug-eluting stents

    Page :876

    Michael Billinger, Lorenz Räber, Sarah Hitz, Giulio G. Stefanini, Thomas Pilgrim, Christoph Stettler, Thomas Zanchin, Cedric Pulver, Nico Pfäffli, Franz Eberli, Bernhard Meier, Bindu Kalesan, Peter Jüni, Stephan Windecker

    Résumé Résumé Plan Plan  
  • ·Progression of atrial fibrillation in the REgistry on Cardiac rhythm disORDers assessing the control of Atrial Fibrillation cohort: Clinical correlates and the effect of rhythm-control therapy

    Page :887-893

    Cees B. De Vos, Günter Breithardt, A. John Camm, Paul Dorian, Peter R. Kowey, Jean-Yves Le Heuzey, Lisa Naditch-Brûlé, Eric N. Prystowsky, Peter J. Schwartz, Christian Torp-Pedersen, William S. Weintraub, Harry J. Crijns

    Résumé Résumé Plan Plan  
  • ·Trends in endocarditis hospitalizations at US children's hospitals: Impact of the 2007 American Heart Association Antibiotic Prophylaxis Guidelines

    Page :894-899

    Sara K. Pasquali, Xia He, Zeinab Mohamad, Brian W. McCrindle, Jane W. Newburger, Jennifer S. Li, Samir S. Shah

    Résumé Résumé Plan Plan  

• Letters to the Editor

  • ·Regarding the “Platelet reactivity in patients with chronic kidney disease receiving adjunctive cilostazol compared with a high-maintenance dose of clopidogrel: Results of the Effect of Platelet Inhibition According to Clopidogrel Dose in Patients with Chronic Kidney Disease (PIANO-2 CKD) randomized study”

    Page :e31

    Dimitrios Alexopoulos

    
  • ·Reply to the letter by Alexopoulos et al “Platelet reactivity in patients with chronic kidney disease receiving adjunctive cilostazol compared with a high-maintenance dose of clopidogrel: Results of the Effect of Platelet Inhibition According to Clopidogrel Dose in Patients with Chronic Kidney Disease (PIANO-2 CKD) randomized study”

    Page :e33

    Jong Shin Woo, Weon Kim

    
  • ·Intensive glycemic control and the risk of heart failure in patients with type 2 diabetes

    Page :e35

    Sebhat Erquo, Chee-Tin Christine Lee, Amanda Adler

    
  • ·Reply to the letter by Dr Erqou regarding “Intensive glycemic control has no impact on the risk of heart failure in type 2 diabetic patients”

    Page :e37

    Davide Castagno, Jonathan Baird-Gunning, Pardeep S. Jhund, Giuseppe Biondi Zoccai, Michael R. MacDonald, Mark C. Petrie, Fiorenzo Gaita, John J.V. McMurray

    
  • ·Preanalytic considerations for using plasma myeloperoxidase as a biomarker in acute coronary syndrome

    Page :e39

    Regent Lee

    
  • ·Myeloperoxidase in the diagnosis of acute coronary syndromes: The importance of spectrum

    Page :e41

    W. Frank Peacock